Safety of therapeutic hypothermia combined with primary percutaneous coronary intervention after out-of-hospital cardiac arrest

Eur Heart J Acute Cardiovasc Care. 2015 Feb;4(1):60-3. doi: 10.1177/2048872614540093. Epub 2014 Jun 18.

Abstract

Background: The safety of therapeutic hypothermia combined with percutaneous coronary intervention (PCI) after out-of-hospital cardiac arrest has been challenged after reports of high risk of stent thrombosis.

Methods: We searched the Western Denmark Heart Registry to identify patients with an acute coronary angiography due to out-of-hospital cardiac arrest performed at our institution between September 2010 and September 2013. We identified 68 unconscious patients, who were resuscitated after out-of-hospital cardiac arrest and underwent acute PCI with stent implantation and immediate therapeutic hypothermia, and followed these for 30 days. Target temperature of 32-34°C was achieved by either an invasive or a non-invasive cooling system.

Results: All patients had elevated myocardial biomarkers and 37 patients had ST-segment elevation myocardial infarction. Bare metal stents were implanted in 14 and drug-eluting stents in 54 patients. All patients received antithrombotic treatment with a standard loading dose of 300 mg acetylsalicylic acid and 10,000 units heparin intravenously prior PCI. Clopidogrel or ticagrelor was administered orally through a gastric tube immediately after PCI. During the procedure abciximab or bivalirudin was administered in 44 patients. Electrocardiographic and clinical signs of stent thrombosis were found in one patient.

Conclusions: We observed one stent thrombosis in this cohort of 68 consecutive patients with out-of-hospital cardiac arrest who were treated with PCI and therapeutic hypothermia. This suggests that PCI with stent implantation can be performed with acceptable safety in these patients.

Keywords: Antithrombotic treatment; ischemic heart disease; out-of-hospital cardiac arrest; percutaneous coronary intervention; safety; stent thrombosis; therapeutic hypothermia.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Combined Modality Therapy
  • Coronary Angiography / methods
  • Drug-Eluting Stents
  • Electrocardiography
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Hypothermia, Induced / adverse effects*
  • Male
  • Middle Aged
  • Myocardial Infarction / therapy*
  • Out-of-Hospital Cardiac Arrest / therapy*
  • Patient Safety
  • Percutaneous Coronary Intervention / adverse effects*
  • Retrospective Studies
  • Stents
  • Treatment Outcome

Substances

  • Biomarkers
  • Fibrinolytic Agents